Razavi Seyed Mehrad, Khayatan Danial, Najafi Arab Zahra, Hosseini Yasamin, Khanahmadi Maryam, Momtaz Saeideh, Jamialahmadi Tannaz, Johnston Thomas P, Abdolghaffari Amir Hossein, Sahebkar Amirhossein
Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences Islamic Azad University Tehran Iran.
GI Pharmacology Interest Group (GPIG) Universal Scientific Education and Research Network (USERN) Tehran Iran.
JOR Spine. 2024 Aug 14;7(3):e1364. doi: 10.1002/jsp2.1364. eCollection 2024 Sep.
In parallel with population aging, the prevalence of neurological and neurodegenerative diseases has been dramatically increasing over the past few decades. Neurodegenerative diseases reduce the quality of life of patients and impose a high cost on the health system. These slowly progressive diseases can cause functional, perceptual, and behavioral deficits in patients. Therefore, neurodegenerative impairments have always been an interesting subject for scientists and clinicians. One of these diseases is spinal cord injury (SCI). SCI can lead to irreversible damage and is classified into two main subtypes: traumatic and non-traumatic, each with very different pathophysiological features.
This review aims to gather relevant information about the beneficial effects of curcumin (Cur), with specific emphasis on its anti-inflammatory properties towards spinal cord injury (SCI) patients.
MATERIALS & METHODS: The review collates data from extensive in-vitro, in-vivo, and clinical trials documenting the effects of CUR on SCI. It examines the modulation of pathophysiological pathways and regulation of the inflammatory cascades after CUR administration.
Various pathophysiological processes involving the nuclear factor erythroid 2-related factor 2 (Nrf2), nuclear factor kappa B (NF-kB), and transforming growth factor beta (TGF-β) signaling pathways have been suggested to exacerbate damages resulting from SCI. CUR administration showed to modulate these signaling pathways which lead to attenuation of SCI complications.
Anti-inflammatory compounds, particularly CUR, can modulate these pathophysiological pathways and regulate the inflammatory cascades. CUR, a well-known natural product with significant anti-inflammatory effects, has been extensively documented in experimental and clinical trials.
Curcumin's potential to alter key steps in the Nrf2, NF-kB, and TGF-β signaling pathways suggests that it may play a role in attenuating SCI complications.
在人口老龄化的同时,过去几十年来,神经和神经退行性疾病的患病率急剧上升。神经退行性疾病降低了患者的生活质量,并给卫生系统带来了高昂的成本。这些缓慢进展的疾病会导致患者出现功能、感知和行为缺陷。因此,神经退行性损伤一直是科学家和临床医生感兴趣的课题。脊髓损伤(SCI)就是其中一种疾病。SCI可导致不可逆的损伤,主要分为两种亚型:创伤性和非创伤性,每种亚型的病理生理特征差异很大。
本综述旨在收集有关姜黄素(Cur)有益作用的相关信息,特别强调其对脊髓损伤(SCI)患者的抗炎特性。
该综述整理了大量体外、体内和临床试验的数据,记录了CUR对SCI的影响。它研究了CUR给药后病理生理途径的调节和炎症级联反应的调控。
涉及核因子红细胞2相关因子2(Nrf2)、核因子κB(NF-κB)和转化生长因子β(TGF-β)信号通路的各种病理生理过程已被认为会加剧SCI造成的损伤。CUR给药显示可调节这些信号通路,从而减轻SCI并发症。
抗炎化合物,特别是CUR,可以调节这些病理生理途径并调控炎症级联反应。CUR是一种具有显著抗炎作用的著名天然产物,已在实验和临床试验中得到广泛记录。
姜黄素改变Nrf2、NF-κB和TGF-β信号通路关键步骤的潜力表明,它可能在减轻SCI并发症方面发挥作用。